Jaw-Ching Wu

Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase–platelet ratio index

Wei-Yu Kao, Yi-Hong Chou, Y. Chou, 2011, European journal of gastroenterology & hepatology.

Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.

Han Chieh Lin, Wen-Chieh Wu, Wei-Yu Kao, 2012, Clinical radiology.

From NPC Therapeutic Target Identification to Potential Treatment Strategy

Chi-Ying F. Huang, Chun-Nan Hsu, Sheng-An Lee, 2010, Molecular Cancer Therapeutics.

Synthetic switch-based baculovirus for transgene expression control and selective killing of hepatocellular carcinoma cells

Yu-Chen Hu, Chin-Wei Chang, Min-Yuan Chou, 2018, Nucleic acids research.